Filing Details
- Accession Number:
- 0000899243-19-019501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-11 21:00:38
- Reporting Period:
- 2019-07-10
- Accepted Time:
- 2019-07-11 21:00:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754145 | A. William Waldegrave | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2019-07-10 | 3,576 | $0.00 | 3,576 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2019-07-10 | 3,576 | $15.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Options | Disposition | 2019-07-10 | 3,576 | $0.00 | 3,576 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,164 | 2019-01-03 | 2028-01-03 | No | 4 | M | Direct |
Footnotes
- Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
- Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.25 U.S. Dollars as of July 10, 2019.
- Represented by ADSs. The sales reported were effected pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on May 10, 2019.
- The price reported in Column 4 is price per ordinary share converted from price per ADS.
- The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 10,740 ordinary shares vesting on January 3, 2021 and expiring on January 3, 2028. The correct vesting schedules for these securities are: 3,680 ordinary shares have vested on January 3, 2019, and the rest will vest equally on January 3, 2020 and January 3, 2021.